Biomarkers of Low-Level Exposure to Soman Vapor: Comparison of Fluoride Regeneration to Acetylcholinesterase Inhibition

REFERENCES

• Aas P., Sterri S. H., Hjermstad H. P., Fonnum F. A method for generating toxic vapors of soman: Toxicity of soman by inhalation in rats. Toxicol. Appl. Pharmacol. 1985; 80: 437–445
   PubMed Web of Science ®Google Scholar
• Adams T. K., Capacio B. R., Smith J. R., Whalley C. E., Korte W. D. The application of the fluoride reactivation process to the detection of sarin and soman nerve agent exposures in biological samples. Drug Chem. Toxicol. 2004; 27: 77–91
   PubMed Web of Science ®Google Scholar
• Bajgar J., Sevelová L., Krejcová G., Fusek J., Vachek J., Kassa J., Herink J., de Jong L. P., Benschop H. P. Biochemical and behavioral effects of soman vapors in low concentrations. Inhal Toxicol 2004; 16: 497–507
   PubMed Web of Science ®Google Scholar
• Barr J. R., Driskell W. J., Aston L. S., Martinez R. A. Quantitation of metabolites of the nerve agents sarin, soman, cyclohexylsarin, VX, and Russian VX in human urine using isotope-dilution gas chromatography-tandem mass spectrometry. J. Anal. Toxicol 2004; 28: 372–378
   PubMed Web of Science ®Google Scholar
• Benschop H. P., Konings C. A. G., Van Genderen J., De Jong L. P. Isolation, anticholinesterase properties, and acute toxicity in mice of the four stereoisomers of the nerve agent soman. Toxicol. Appl. Pharmacol. 1984; 72: 61–74
   PubMed Web of Science ®Google Scholar
• Benschop H. P., Bijleveld E. C., De Jong L. P. Toxicokinetics of soman: Species variation and stereospecificity in elimination pathways. Neurosci. Biobehav. Rev. 1991; 15: 73–77
   PubMedGoogle Scholar
• Benschop H. P., Trap H. C., Spruit H. E., Van Der Wiel H. J., Langenberg J. P., De Jong L. P. Low level nose-only exposure to the nerve agent soman: toxicokinetics of soman stereoisomers and cholinesterase inhibition in atropinized guinea pigs. Toxicol. Appl. Pharmacol. 1998; 153: 179–185
   PubMed Web of Science ®Google Scholar
• Black R. M., Harrison J. M., Read R. W. The interaction of sarin and soman with plasma proteins: the identification of a novel phosphonylation site. Arch. Toxicol. 1999; 73: 123–126
   PubMed Web of Science ®Google Scholar
• Choi B. K., Gusev A. I., Hercules D. M. Postcolumn introduction of an internal standard for quantitative LC-MS analysis. Anal. Chem 1999; 71: 4107–4110
   Google Scholar
• Dabisch P. A., Miller D. B., Reutter S. A., Mioduszewski R. J., Thomson S. A. Miotic tolerance to sarin vapor exposure: role of the sympathetic and parasympathetic nervous systems. Toxicol. Sci. 2005; 85: 1041–1047
   PubMed Web of Science ®Google Scholar
• Degenhardt C. E., Pleijsier K., van der Schans M. J., Langenberg J. P., Preston K. E., Solano M. I., Maggio V. L., Barr J. R. Improvements of the fluoride reactivation method for the verification of nerve agent exposure. J Anal Toxicol 2004; 28: 364–371
   PubMed Web of Science ®Google Scholar
• Due A. H., Trap H. C., Langenberg J. P., Benschop H. P. Toxicokinetics of soman stereoisomers after subcutaneous administration to atropinized guinea pigs. Arch Toxicol. 1994; 68: 60–63
   PubMed Web of Science ®Google Scholar
• Ecobichon D. J. Toxic effects of pesticides. Casarett and Doull's toxicology: The basic science of poisons, 6th ed., C. D. Klaassen. McGraw-Hill, New York 2001; 763–783
   Google Scholar
• Ellman G. L., Courtney K. D., Andres V., Feather-Stone R. M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 1961; 7: 88–95
   PubMed Web of Science ®Google Scholar
• Fidder A., Hulst A. G., Noort D., de Ruiter R., van der Schans M. J., Benschop H. P., Langenberg J. P. Retrospective detection of exposure to organophosphorus anticholinesterases: Mass spectrometric analysis of phosphylated human butyrylcholinesterase. Chem. Res. Toxicol. 2002; 15: 582–590
   PubMed Web of Science ®Google Scholar
• Institute of Laboratory Animal Resources, Commission of Life Sciences, National Research Council. Guide for the care and use of laboratory animals. National Academy Press, Washington, DC 1996
   Google Scholar
• Jakubowski E. M., McGuire J. M., Evans R. A., Edwards J. L., Hulet S. W., Benton B. J., Forster J. S., Burnett D. C., Muse W. T., Matson K., Crouse C., Mioduszewski R. J., Thomson S. A. Quantitation of fluoride ion released sarin in red blood cell samples by gas chromatography–chemical ionization mass spectrometry using isotope dilution and large-volume injection. J. Anal. Toxicol. 2004; 28: 357–363
   PubMed Web of Science ®Google Scholar
• Langenberg J. P., van Dijk C., Sweeney R. E., Maxwell D. M., De Jong L. P., Benschop H. P. Development of a physiologically based model for the toxicokinetics of C(+/–)P(+/–)-soman in the atropinized guinea pig. Arch Toxicol. 1997; 71: 320–331
   PubMed Web of Science ®Google Scholar
• Langenberg J. P., Spruit H. E., van der Wiel H. J., Trap H. C., Helmich R. B., Bergers W. W., van Helden H. P., Benschop H. P. Inhalation toxicokinetics of soman stereoisomers in the atropinized guinea pig with nose-only exposure to soman vapor. Toxicol. Appl. Pharmacol. 1998; 151: 79–87
   PubMed Web of Science ®Google Scholar
• Maxwell D. M., Vlahacos C. P., Lenz D. E. A pharmacodynamic model for soman in the rat. Toxicol. Lett. 1988; 43: 175–188
   PubMed Web of Science ®Google Scholar
• Muse W. T., Thomson S., Crouse C., Matson K. Generation, sampling, and analysis for low-level GB (sarin) and GF (cyclosarin) vapor for inhalation toxicology studies. Inhal. Toxicol. 2006; 18: 1101–1108
   PubMed Web of Science ®Google Scholar
• Nordgren I., Lundgren G., Puu G., Holmstedt B. Stereoselectivity of enzymes involved in toxicity and detoxification of soman. Arch. Toxicol. 1984; 55: 70–75
   PubMed Web of Science ®Google Scholar
• Noort D., Fidder A., van der Schans M. J., Hulst A. G. Verification of exposure to organophosphates: Generic mass spectrometric method for detection of human butyrylcholinesterase adducts. Anal. Chem. 2006; 78: 6640–6644
   PubMedGoogle Scholar
• Polhuijs M., Langenberg J. P., Noort D., Hulst A. G., Benschop H. P. Retrospective detection of exposure to organophosphates: analyses in blood of human beings and rhesus monkeys. NBC risks: Current capabilities and future perspectives for protection, T. Sohms, V. A. Voicu. Kluwer Academic, DordrechtThe Netherlands 1998; 513–521
   Google Scholar
• Shih M. L., McMonagle J. D., Dolzine T. W., Gresham V. C. Metabolite pharmacokinetics of soman, sarin, and gf rats and biological monitoring of exposure to toxic organophosphorus agents. J. Appl. Toxicol. 1994; 14: 195–199
   PubMed Web of Science ®Google Scholar
• Sim V. M. Effect on pupil size of exposure to sarin vapour. 1956, Directorate of Chemical Defence Research and Development—Porton Technical Paper #531. DTIC number AD 092597
   Google Scholar
• Singh A. K., Zeleznikar R. J., Drewes L. R. Analysis of soman and sarin in blood utilizing a sensitive gas chromatography–mass spectrometry method. J. Chromatogr 1985; 17(324)163–172
   Google Scholar
• Sweeney R. E., Langenberg J. P., Maxwell D. M. A physiologically based pharmacokinetic (PB/PK) model for multiple exposure routes of soman in multiple species. Arch. Toxicol 2006; 80: 719–731
   PubMed Web of Science ®Google Scholar
• Taylor P. Anticholinesterase agents. Goodman and Gilman's The pharmacological basis of therapeutics, 11th ed., L. E. Limbird, J. G. Hardman. McGraw-Hill, New York 2006; 201–216
   Google Scholar
• U.S. Army Medical Research Institute for Chemical Defense. Nerve agents: GA, GB, GD, GF, VX. Medical management of chemical casualties handbook, 3rd ed. USAMRICD, Aberdeen Proving Ground, MD 2000; 102–135
   Google Scholar
• van der Schans M. J., Polhuijs M., van Dijk C., Degenhardt C. E., Pleijsier K., Langenberg J. P., Benschop H. P. Retrospective detection of exposure to nerve agents: Analysis of phosphofluoridates originating from fluoride-induced reactivation of phosphylated BuChE. Arch. Toxicol. 2004; 78: 508–524
   PubMed Web of Science ®Google Scholar